BridgeBio Pharma Stock Forecast

Stock Price Forecast

The 12 analysts with 12-month price forecasts for BridgeBio Pharma stock have an average target of 48.33, with a low estimate of 37 and a high estimate of 70. The average target predicts an increase of 69.22% from the current stock price of 28.56.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$37	$48.33	$47	$70
Change	+29.55%	+69.22%	+64.57%	+145.10%

Analyst Ratings

The average analyst rating for BBIO stock from 13 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Aug '24	Sep '24	Oct '24	Nov '24	Dec '24	Jan '25
Strong Buy	5	5	5	5	5	5
Buy	3	4	6	6	6	6
Hold	1	1	2	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	9	10	13	13	13	13

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Cory Kasimov Evercore ISI Group	Evercore ISI Group	Buy Maintains $45 → $50	Buy	Maintains	$45 → $50	+75.07%	Dec 23, 2024
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $49	Strong Buy	Reiterates	$49	+71.57%	Dec 16, 2024
Greg Harrison Scotiabank	Scotiabank	Buy Maintains $45 → $48	Buy	Maintains	$45 → $48	+68.07%	Nov 25, 2024
Geoff Meacham B of A Securities	B of A Securities	Strong Buy Maintains $42 → $45	Strong Buy	Maintains	$42 → $45	+57.56%	Nov 25, 2024
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $43 → $49	Strong Buy	Maintains	$43 → $49	+71.57%	Nov 25, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

223.92M

from 9.30M

2,306.97%

from 9.30M

Revenue Next Year

184.33M

from 223.92M

-17.68%

from 223.92M

EPS This Year

-2.67

from -3.95

EPS Next Year

-3.77

from -2.67

Fiscal Year	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	40.56M	8.25M	69.72M	77.65M	9.30M	223.92M	184.33M	416.20M
Revenue Growth	-	-79.66%	745.14%	11.38%	-88.02%	2,306.97%	-17.68%	125.79%
EPS	-2.48	-3.80	-3.90	-3.26	-3.95	-2.67	-3.77	-2.92
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	20	20	16

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024	2025	2026
High	244.2M	360.2M	678.3M
Avg	223.9M	184.3M	416.2M
Low	211.7M	55.8M	209.2M

Revenue Growth

Revenue Growth	2024	2025	2026
High	2,524.4%	60.9%	268.0%
Avg	2,307.0%	-17.7%	125.8%
Low	2,175.4%	-75.1%	13.5%

EPS Forecast

EPS	2024	2025	2026
High	-2.47	-2.65	-1.80
Avg	-2.67	-3.77	-2.92
Low	-2.95	-4.42	-3.75

EPS Growth

EPS Growth	2024	2025	2026
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.